Skip to content

A double-blind, placebo controlled, randomized trial to evaluate the efficacy of SE in post-stroke rehabilitation patients.

A double-blind, placebo controlled, randomized trial to evaluate the efficacy of SE in post-stroke rehabilitation patients. - A double-blind, placebo controlled, randomized trial to evaluate the efficacy of SE in post-stroke rehabilitation patients.

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000012902
Enrollment
40
Registered
2014-01-27
Start date
2013-11-01
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Stroke

Interventions

SE(Extract of Citrus species) Placebo

Sponsors

Tokyo Bay Rehabilitation Hospital
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: 1. Aged 50 or older 2. Primary disease is first ever stroke 3. Within two weeks after admission 4. SIAS Knee-Extension Test score is within 3 5. Patients who can ride normal wheelchair

Exclusion criteria

Exclusion criteria: 1. Impossible to get informed concent by cognitive deficit 2. Impossible to be treated with exercise therapy due to complication or previous disease 3. Impossible to swallow experimental food 4. Patients who receive parenteral or enteral Nutrition 5. peel of citrus species supplementation 6. Patients who are judged inappropriate for the study by the physician

Design outcomes

Primary

MeasureTime frame
Skeletal muscle mass (BIA, thigh muscle area by Computed tomography)

Countries

Japan

Contacts

Public ContactKaoru Honaga

Tokyo Bay Rehabilitation Hospital Rehabilitation Department

rh_fortune@hotmail.com047-453-9000

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026